Learn more about our Regulatory Affairs work.
Recently, Nadim Yared joined host Scott Whitaker on the Medtech POV Podcast in a 2-part episode to discuss his expansive career, transition to a startup company and work with the…
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity…
Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today that the Centers for Medicare & Medicaid…
Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of…
Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that it has closed a $4M Series A funding round led by the Horowitz Group, a…
Justin Klein recently joined AdvaMed® CEO Scott Whitaker for an episode of Medtech POV to talk about his expansive career in medtech and some of today’s most pressing issues across…
Well-crafted tax policy on NOLs spurs innovation in new life-saving treatments and cures; and as we continue to emerge from the pandemic, there is no time more important for the…
As medtech and the health care system drive us closer to the pandemic’s end, reflexive and ill-conceived antitrust policy targeting medical technology companies risks thwarting innovation, foreclosing patient access to…
President and CEO of AdvaMed® Scott Whitaker sent a letter to President Biden on behalf of the medical technology industry asking “the Administration to make the transport of medical supplies…
The long-term implications of state right-to-repair laws could have devastating consequences for health care providers and their patients.